BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 10189392)

  • 21. Human vascular smooth muscle cells express functionally active endothelial cell protein C receptor.
    Bretschneider E; Uzonyi B; Weber AA; Fischer JW; Pape R; Lötzer K; Schrör K
    Circ Res; 2007 Feb; 100(2):255-62. PubMed ID: 17170365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous protein C activation in patients with severe sepsis.
    Liaw PC
    Crit Care Med; 2004 May; 32(5 Suppl):S214-8. PubMed ID: 15118520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis.
    Esmon CT
    Baillieres Clin Haematol; 1994 Sep; 7(3):453-68. PubMed ID: 7841595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Protein C and coagulation in sepsis].
    D'Angelo A; Della Valle P; Giudici D; Viganò D'Angelo S
    Minerva Anestesiol; 2004 May; 70(5):339-50. PubMed ID: 15181414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands.
    Bangalore N; Drohan WN; Orthner CL
    Thromb Haemost; 1994 Sep; 72(3):465-74. PubMed ID: 7855799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of inflammation by the protein C system.
    Weiler H
    Crit Care Med; 2010 Feb; 38(2 Suppl):S18-25. PubMed ID: 20083909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crosstalk between inflammation and coagulation: the lessons of sepsis.
    van der Poll T; Levi M
    Curr Vasc Pharmacol; 2012 Sep; 10(5):632-8. PubMed ID: 22272914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulopathy of Acute Sepsis.
    Semeraro N; Ammollo CT; Semeraro F; Colucci M
    Semin Thromb Hemost; 2015 Sep; 41(6):650-8. PubMed ID: 26305237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation.
    Cariou R; Tobelem G; Bellucci S; Soria J; Soria C; Maclouf J; Caen J
    Thromb Haemost; 1988 Aug; 60(1):54-8. PubMed ID: 2847352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of the inflammatory response on coagulation.
    Esmon CT
    Thromb Res; 2004; 114(5-6):321-7. PubMed ID: 15507261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation and functions of the protein C anticoagulant pathway.
    Esmon CT; Gu JM; Xu J; Qu D; Stearns-Kurosawa DJ; Kurosawa S
    Haematologica; 1999 Apr; 84(4):363-8. PubMed ID: 10190952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular biology of protein C-thrombomodulin pathway. Structure and function, and basic studies on its clinical application].
    Hayashi T; Suzuki K
    Nihon Rinsho; 1993 Jun; 51(6):1610-9. PubMed ID: 8391599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-way interactions between inflammation and coagulation.
    Levi M; van der Poll T
    Trends Cardiovasc Med; 2005 Oct; 15(7):254-9. PubMed ID: 16226680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The endothelial cell protein C receptor.
    Esmon CT
    Thromb Haemost; 2000 May; 83(5):639-43. PubMed ID: 10823253
    [No Abstract]   [Full Text] [Related]  

  • 35. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.
    Esmon CT
    Crit Care Med; 2001 Jul; 29(7 Suppl):S48-51; discussion 51-2. PubMed ID: 11445734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of endothelial cell injury by activated protein C: the molecular mechanism(s) and therapeutic implications.
    Okajima K
    Curr Vasc Pharmacol; 2004 Apr; 2(2):125-33. PubMed ID: 15320513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation and thrombosis: the impact of inflammation on the protein C anticoagulant pathway.
    Esmon CT
    Haematologica; 1995; 80(2 Suppl):49-56. PubMed ID: 7628771
    [No Abstract]   [Full Text] [Related]  

  • 38. Overview of the postulated mechanisms linking cancer and thrombosis.
    ten Cate H; Falanga A
    Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo.
    Gu JM; Katsuura Y; Ferrell GL; Grammas P; Esmon CT
    Blood; 2000 Mar; 95(5):1687-93. PubMed ID: 10688825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.